SCHEMBL4096498

SCHEMBL4096498

COc1ccc(CCNCc2ccccc2[N+](=O)[O-])cc1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.63
MAPT P10636 4/20 0.63
KDM4E B2RXH2 3/20 0.63
GAA P10253 1/20 0.63
MAPK1 P28482 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
SMPD1 P17405 1/20 0.62
SMN1; SMN2 Q16637 2/20 0.61
CYP1A2 P05177 2/20 0.59
CYP3A4 P08684 2/20 0.59
CYP2C19 P33261 2/20 0.59
KMT2A Q03164 5/20 0.57
MEN1 O00255 4/20 0.55
CYP2D6 P10635 1/20 0.54
TAAR1 Q96RJ0 1/20 0.54
ALOX15 P16050 1/20 0.54
GLA P06280 1/20 0.52
PTPN1 P18031 1/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7265571 0.84 ALDH1A1 (0.51) ALDH1A1MAPTKDM4EGAAMAPK1
SCHEMBL7265171 0.83 ALDH1A1 (0.50) ALDH1A1MAPTKDM4EGAAMAPK1
SCHEMBL30068226 0.82 ALDH1A1 (0.58) ALDH1A1MAPTKDM4EGAAMAPK1
SCHEMBL6038195 0.81 MAPT (0.69) ALDH1A1MAPTKDM4EGAAMAPK1
SCHEMBL2036624 0.81 KDM4E (0.55) ALDH1A1MAPTKDM4ESMN1; SMN2CYP1A2
SCHEMBL4114614 0.80 CA12 (0.59) ALDH1A1MAPTKDM4ESMN1; SMN2CYP1A2
SCHEMBL4103633 0.80 SMPD1 (0.70) ALDH1A1KDM4EMAPK1SMPD1SMN1; SMN2
SCHEMBL4103880 0.79 SMPD1 (0.69) ALDH1A1MAPTKDM4ESMPD1SMN1; SMN2
SCHEMBL3215060 0.78 ALDH1A1 (0.61) ALDH1A1MAPTKDM4EGAAMAPK1
SCHEMBL7266960 0.77 ALDH1A1 (0.50) ALDH1A1MAPTKDM4EGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221829-A1 3,4-Dihydroisoquinolinium Salt Derivatives HANWHA CHEMICAL CORPORATION (KR) 2009-09-03 US disclosed
EP-1896419-A1 3,4-DIHYDROISOQUINOLINIUM SALT DERIVATIVES HANWHA CHEMICAL CORPORATION (KR) 2008-03-12 EP disclosed
WO-2006129978-A1 3,4-DIHYDROISOQUINOLINIUM SALT DERIVATIVES HANWHA CHEMICAL CORPORATION (KR) 2006-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221829-A1 3,4-Dihydroisoquinolinium Salt Derivatives KCNQ3, KCNQ1, KCNQ2 ALDH1A1 369/4885MAPT 1375/4885KDM4E 1933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.